Literature DB >> 17823187

Should terminally ill patients have the right to take drugs that pass phase I testing? Yes.

Emil J Freireich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17823187      PMCID： PMC1971171          DOI： 10.1136/bmj.39244.451192.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Should the FDA be the doctor of last resort?

Authors:  Vincent T DeVita
Journal:  Nat Clin Pract Oncol       Date:  2005-09

2.  Phase III trials in oncology: setting standards of care?

Authors:  Siegfried Seeber; Ada H Braun
Journal:  Nat Clin Pract Oncol       Date:  2005-09

3.  The investigational new drug application--who benefits?

Authors:  Emil J Freireich
Journal:  Nat Clin Pract Oncol       Date:  2006-02
  3 in total
  2 in total

Review 1.  Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review.

Authors:  Sigrid Droste; Annegret Herrmann-Frank; Fueloep Scheibler; Tanja Krones
Journal:  BMC Med Ethics       Date:  2011-04-15       Impact factor: 2.652

2.  Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.

Authors:  Jeremiah Stout; Cambray Smith; Jan Buckner; Alex A Adjei; Mark Wentworth; Jon C Tilburt; Zubin Master
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.